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TGA, DICER1 13 14 Findings 15 DICER1 is an endoribonuclease that plays an essential role in modulating the expression of genes by 16 producing mature microRNAs (miRNA), which are small, single stranded RNA molecules that bind to 17 and thereby inhibit target mRNAs. DICER1-related diseases are referred to collectively as DICER1 18 syndrome and result from germline mutations in individuals with rare childhood cancers such as: 19 pleuropulmonary blastoma, cystic nephroma, Sertoli-Leydig cell tumor, embryonal rhabdomyosarcoma 20 and other rare tumors[1] [. Several years ago, we identified a deleterious germline DICER1 mutation 21 (c.2117-1G>A, in intron 13 at the junction with exon 14, predicted to result in p.Gly706Aspfs*8) in a 22 child with transposition of the great arteries (TGA), associated with a bicuspid pulmonary valve, an atrial 23 septal defect and a patent ductus arteriosus [2] ]. Later, at the age of 18, he developed a solitary nodule in 24 the left lobe of the thyroid gland. Two years later, he was found to have further nodules and cysts in the 25 same lobe. Other mutation-carrying persons in the family also had phenotypes consistent with the 26 DICER1syndrome [2]. Saxena and Tabin had reported cardiac outflow defects in mice with a conditional 27 knock-out of Dicer in the developing murine heart [3]. These two observations prompted us to screen for 28 DICER1 mutations in familial and sporadic cases with TGA. TGA is a cyanotic congenital heart defect 29 (CHD) characterized by ventriculo-arterial discordance and represents 5 to 7% of CHD [4] . It is often 30 accompanied by other structural changes that allow mixing of oxygenated and de-oxygenated blood, 31
although there have been studies looking for the genetic causes of TGA, data so far have been 32 inconclusive [5] . 33
34
We screened 129 germline DNA samples from children with sporadic (n = 91) or familial (n = 38) forms 35 of TGA for DICER1 mutations using a Fluidigm access array, followed by next-generation sequencing 36 and confirmatory Sanger sequencing [6] . Eighty-two cases were from Australia and 47 were from Italy. 37
Details of the cases studied are shown in Supplementary Table 1 . All patients signed an IRB-approved 38 consent form. 39
40
No DICER1 variants were detected in 110 cases. Nineteen individuals had one or more variants for a total 41 of 5 synonymous, 7 intronic and 6 missense variants ( Supplementary Table 2 ). c.307+13T>C and 42 c.4886C>T are novel intronic and missense variants, respectively. c.4886C>T results in a protein with an 43 amino acid change at position 1629, from serine to proline, (p.S1629L). SIFT (Sorting Intolerant from 44 Tolerant)[7] and Polyphen 2 (Polymorphism Phenotyping-2)[8] predicted this variant to be "tolerated and 45 benign", respectively. Predictions for the other missense variants varied from possibly damaging to 46 benign by Polyphen 2, but all variants identified were predicted to be tolerated by SIFT (supplementary table 2). No definitively damaging mutations in DICER1 were found. In particular, we did not identify 48 any mutations predicted to result in a truncated protein. Thus far, most disease-associated germline 49 mutations in DICER1 are predicted to truncate the protein [1] . 50 3 This study suggests that TGA is not caused by DICER1 mutations in humans. The full spectrum of 51 phenotypes associated with DICER1 mutations is still being defined, and newly-associated phenotypes 52 such as pituitary blastoma[6] and macrocephaly [9] are still emerging. As such, it is important to fully 53 explore all possible associations. Here we report that TGA does not appear to be part of the DICER1 54 syndrome. The genetics of TGA remain enigmatic [4] and it is likely that whole genome approaches in a 55 large series of cases will be required to identify causal variants and genetic modifiers. 
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